Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,998 | -20,470 | -17,996 | -7,955 | -31,440 |
| Depreciation Amortization | 3,133 | 2,244 | 1,455 | 697 | 1,990 |
| Accounts receivable | -6,860 | -5,097 | -1,703 | -1,454 | -1,224 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 375 | N/A |
| Other Working Capital | -13,667 | -13,104 | -4,996 | -2,220 | 71,091 |
| Other Operating Activity | 7,928 | 5,994 | 2,487 | 1,612 | 4,035 |
| Operating Cash Flow | $-38,464 | $-30,433 | $-20,753 | $-8,945 | $44,452 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,855 | -6,816 | -5,473 | -2,961 | -6,122 |
| Other Investing Activity | -137 | -101 | -60 | -42 | -52 |
| Investing Cash Flow | $-7,992 | $-6,917 | $-5,533 | $-3,003 | $-6,174 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 501 | 159 | 27 | 2 | 293 |
| Financing Cash Flow | $501 | $159 | $27 | $2 | $293 |
| Exchange Rate Effect | 589 | 326 | -46 | 44 | 99 |
| Beginning Cash Position | 81,266 | 81,266 | 81,266 | 81,266 | 42,596 |
| End Cash Position | 35,900 | 44,401 | 54,961 | 69,364 | 81,266 |
| Net Cash Flow | $-45,366 | $-36,865 | $-26,305 | $-11,902 | $38,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,464 | -30,433 | -20,753 | -8,945 | 44,452 |
| Capital Expenditure | -7,855 | -6,816 | -5,473 | -2,961 | -6,195 |
| Free Cash Flow | -46,319 | -37,249 | -26,226 | -11,906 | 38,257 |